$HYEX Healthy Extracts Expects 2024 Net Revenue Up 24%,

New Post Public Reply Private Reply Replies (0) Message Board
louied91
104
$HYEX Healthy Extracts Expects 2024 Net Revenue Up 24%, Driving Positive Cash Flow

https://www.accesswire.com/968138/healthy-ext...-cash-flow

Results Driven by 80% Growth in Subscription-Based Recurring Revenue, Strengthening Customer Retention and Lifetime Value (LTV)

LAS VEGAS, NV / ACCESSWIRE / January 14, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), an innovative platform for acquiring, developing, patenting, marketing and distributing plant-based nutraceuticals, expects to report record results for the year ended December 31, 2024.

For full year 2024, net revenue is expected to exceed a record $3.1 million, up 24% year-over-year. Combined with strong margin performance, the revenue growth is expected to drive positive operating cash flow for the year.

"Our anticipated record-breaking revenue and profits for the year reflects strong performance across our direct-to-consumer channels and our strengthening momentum with key retail partners," commented Healthy Extracts president, Duke Pitts.

"We believe our focus on customer retention, product quality and innovation, and strategic customer engagement continues to set us apart from the competition," added Pitts. "We have also been effective in leveraging our expertise to dominate key sales channels, like Amazon, where we see the potential to generate millions in additional annual sales with each new product launch."

Healthy Extracts' record Amazon sales in 2024 was demonstrated by its top three ranking in its category, and this resulting from its optimized sales and marketing efforts.

The company's successful "Subscribe & Save" program for both Amazon and direct-to-consumer sales boosted its recurring revenue stream, up 80% year-over-year, while strengthening customer retention and lifetime value (LTV).

2025 Outlook

"As we begin the new year, we are looking forward to building upon our success in 2024 with the launch of a new series of groundbreaking products," continued Pitts. "Targeting for release during the first quarter, these new products will be specifically formulated for new high-growth categories."

These anticipated new products include a groundbreaking on-the-go hydration product; an easy-to-consume sugar blocker; and a revolutionary heart health formulation targeting the more than 40 million statin users in the U.S.

The hydration and sugar blocker represent new category entries for the company, while the new heart health product is expected to expand this most successful category for the company to new levels.

All of these products will tap the company's well-established customer base, while attracting new audiences and creating significant cross-selling opportunities.

"We enter 2025 with solid cash flow, manageable debt, and a highly favorable capitalization structure," said Pitts. "This strong position supports our outlook for another year of record growth. We also see our M&A opportunities further strengthening our positive outlook and enhancing our ability to deliver greater shareholder value."

The preliminary unaudited results provided in this press release are estimates only and subject to change without notice until the company officially reports its audited annual results in March.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 16

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 21

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 13

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 22

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Historic Silver Surge Sparks Investment Opportunities in Resources

Updated Category News Views 83

Understanding the Recent Silver Surge The recent spike in silver prices, surpassing $100 per ounce, marks a transformative moment in the commodity market. This extraordinary increase shifts the focus from mere speculation to real value creation driven by tangible resource discoveries. The new dynamics of the silver supply chain, particularly influenced by policy changes...

Continue Reading
Discovering the Unique Blend of Grange La Chapelle 2021

Updated Category News Views 256

Unveiling Grange La Chapelle 2021 Grange La Chapelle 2021 is more than just a wine; it is a remarkable fusion of cultures and traditions. This exquisite blend uniquely brings together the storied heritage of French wine-making and the innovative spirit found in Australian viticulture. The collaboration between celebrated wine legends embodies the essence of curiosity and...

Continue Reading
California Parents Rally Against CBD Ban Impacting Children

Updated Category News Views 94

California Parents Rally Against CBD Ban Affecting Their Children A group of concerned parents in California is reacting strongly to a proposed ban on hemp products containing THC that Governor Gavin Newsom has put forth. This emergency measure poses a significant threat to essential treatments that many children with chronic and rare diseases depend on, especially those...

Continue Reading
Aegis Resources Ltd. Completes Stock Options Grant to Key Players

Updated Category News Views 276

Aegis Resources Ltd. Grants Stock Options to Directors and Consultants Aegis Resources Ltd. announces an exciting new development with the grant of 3,625,000 stock options to four directors and selected consultants. This is a strategic move aimed at strengthening its management team while aligning their interests with the company's growth. The options come with an...

Continue Reading
Alphabet Inc's Shares Dip as Competition Heats Up with OpenAI

Updated Category News Views 248

Stock Performance Overview Alphabet Inc (NASDAQ: GOOG) has experienced a noticeable dip in its stock value following OpenAI's recent announcement of ChatGPT Atlas, a new AI-powered web browser. This introduction is perceived as a direct challenge to Google's dominance in the search engine and web browser markets, prompting a wave of market reactions from investors....

Continue Reading